# Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5

Study · id `cardio:ct-nct05544864` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05544864](<https://clinicaltrials.gov/study/NCT05544864>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05544864

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 376 participants.

## Technical summary

Registry record NCT05544864. Randomized; no masking; primary purpose treatment. Start 2022-09-28 (actual); primary completion 2026-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 376 participants (planned count; ClinicalTrials.gov record NCT05544864, source copy `cardio:ctgov-nct05544864-2025-01-06`, retrieved 2026-10-26)
- Started: 2022-09-28 (actual) (ClinicalTrials.gov record NCT05544864, source copy `cardio:ctgov-nct05544864-2025-01-06`, retrieved 2026-10-26)
- Primary completion: 2026-09 (anticipated) (ClinicalTrials.gov record NCT05544864, source copy `cardio:ctgov-nct05544864-2025-01-06`, retrieved 2026-10-26)
- Completion: 2026-09 (anticipated) (ClinicalTrials.gov record NCT05544864, source copy `cardio:ctgov-nct05544864-2025-01-06`, retrieved 2026-10-26)
- Countries: Germany; Spain (ClinicalTrials.gov record NCT05544864, source copy `cardio:ctgov-nct05544864-2025-01-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05544864-2025-01-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
- Acronym: ISAR-DESIRE5
- Condition: Coronary Artery Disease
- Condition: Restenoses, Coronary
- Intervention (Device): Drug eluting stent (DES)
- Intervention (Device): Drug coated ballloon (DCB)
- Lead sponsor: Deutsches Herzzentrum Muenchen
- Lead sponsor class: OTHER
- Collaborator: EvidentIQ Germany GmbH
- Collaborator class: UNKNOWN
- Collaborator: Abbott
- Collaborator class: INDUSTRY
- Collaborator: Technical University of Munich
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Deutsches Herzzentrum Muenchen (`cardio:org-deutsches-herzzentrum-muenchen`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)
- Registry lists this organization as a collaborator: Technical University of Munich (`cardio:org-technical-university-of-munich`)

## Provenance

Content hash: 72b373242bdd3faa39c62ffe2c5b5bad2593649214d5b29318835b1fd0a7ea58
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
